What is Catalyst Pharmaceutical's change in AR?

Catalyst Pharmaceutical (CPRX) reported change in AR of $4.36M in Q1 2026.

How has Catalyst Pharmaceutical's change in AR changed year-over-year?

Catalyst Pharmaceutical's change in AR decreased by 24.7% year-over-year, from $5.79M to $4.36M.

What is the long-term trend for Catalyst Pharmaceutical's change in AR?

Over 2 years (2021 to 2025), Catalyst Pharmaceutical's change in AR has grown at a 920.2% compound annual growth rate (CAGR), from $638K to $66.4M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Catalyst Pharmaceutical CPRX Change in AR

Change in AR at other companies

Acadia PharmaceuticalsACAD

$13.89M+98.4%

Amneal Pharmaceuticals, Inc.AMRX

-$44.01M-108%

Rhythm Pharmaceuticals, Inc.RYTM

$8.11M+1,280%

Mirum Pharmaceuticals, Inc.MIRM

$12.89M-23.4%

BridgeBio PharmaBBIO

$65.78M-40.5%

Neurocrine BiosciencesNBIX

$81.4M+121%

Other financials

Income statement

See full

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

See full

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

See full

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

See full

Market cap$3.84B+2.7%

Enterprise value$3.09B-4.1%

P/E17.4×-1.6×

P/S6.4×-0.6×

Profitability

See full

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

See full

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's change in AR?: Catalyst Pharmaceutical (CPRX) reported change in AR of $4.36M in Q1 2026.
How has Catalyst Pharmaceutical's change in AR changed year-over-year?: Catalyst Pharmaceutical's change in AR decreased by 24.7% year-over-year, from $5.79M to $4.36M.
What is the long-term trend for Catalyst Pharmaceutical's change in AR?: Over 2 years (2021 to 2025), Catalyst Pharmaceutical's change in AR has grown at a 920.2% compound annual growth rate (CAGR), from $638K to $66.4M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.